0000897069-23-001136.txt : 20230809
0000897069-23-001136.hdr.sgml : 20230809
20230809165120
ACCESSION NUMBER: 0000897069-23-001136
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230808
FILED AS OF DATE: 20230809
DATE AS OF CHANGE: 20230809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ng George K
CENTRAL INDEX KEY: 0001638744
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39531
FILM NUMBER: 231155967
MAIL ADDRESS:
STREET 1: C/O SORRENTO THERAPEUTICS, INC.
STREET 2: 6042 CORNERSTONE COURT WEST, SUITE B
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001533743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451539785
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
BUSINESS PHONE: 443-776-3133
MAIL ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
FORMER COMPANY:
FORMER CONFORMED NAME: Heatwurx, Inc.
DATE OF NAME CHANGE: 20111028
4
1
form4.xml
X0508
4
2023-08-08
0001533743
Processa Pharmaceuticals, Inc.
PCSA
0001638744
Ng George K
C/O PROCESSA PHARMACEUTICALS, INC.
7380 COCA COLA DRIVE, SUITE 106
HANOVER
MD
21076
true
Chief Executive Officer
false
Restricted Stock Units
0
2023-08-08
4
A
0
400000
0
A
Common Stock
400000
400000
D
Restricted Stock Units
0
2023-08-08
4
A
0
400000
0
A
Common Stock
400000
800000
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of one-third on 08/08/24, 08/08/25, and 08/08/26 or upon a change in control event.
The restricted stock units vest upon the achievement of certain performance goals.
/s/ George Ng, by Neda A. Sharifi, as Attorney-in-Fact
2023-08-09